Name: Pyxis Oncology, Inc. (PYXS) Financial Statements
Creator: FinSpry

Pyxis Oncology Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Pyxis Oncology, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	16.15	1.78	0.00	0.00	0.00
Cost of Revenue	0.48	0.00	0.00	0.00	0.00
Gross Profit	15.67	1.78	0.00	0.00	0.00
Operating Expenses
Research & Development	58.75	49.59	86.13	51.05	9.05
Selling, General & Administrative	22.49	30.83	37.35	18.66	3.85
Operating Expenses	81.24	80.42	123.48	69.72	12.89
Operating Income	-65.57	-80.42	-123.48	-69.72	-12.89
Other Income/Expense
Interest Income	7.04	6.63	2.76	0.02	0.07
Interest Expense	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	9.97	1.78	-2.76	-6.28	0.00
Income
Income Before Tax	-79.50	-73.79	-120.72	-75.98	-12.83
Income Tax Expense	-2.16	0.00	0.00	0.00	0.00
Net Income	-77.33	-73.79	-120.72	-75.98	-12.83
Net Income - Continuous Operations	-77.33	-73.79	-120.72	-75.98	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-62.59	-78.49	-122.77	-69.07	-12.43
EBIT	-65.57	-80.42	-123.48	-69.72	-12.89
Depreciation & Amortization	2.98	1.93	0.71	0.65	0.47
Earnings Per Share
Basic EPS	-1.00	-2.00	-4.00	-9.00	-12.00
Diluted EPS	-1.00	-2.00	-4.00	-9.00	-12.00
Basic Shares Outstanding	58.45	39.90	33.03	8.49	1.03
Diluted Shares Outstanding	58.45	39.90	33.03	8.49	1.03